XML 20 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Unaudited Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Underwritten Offering
Private Placement
Preferred Stock
Common Stock
Common Stock
Underwritten Offering
Common Stock
Private Placement
Additional paid-in capital
Additional paid-in capital
Underwritten Offering
Additional paid-in capital
Private Placement
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2019       0 49,627              
Balance at beginning of period at Dec. 31, 2019 $ 117,203     $ 0 $ 50     $ 597,679     $ (480,526)  
Increase (Decrease) in Stockholders' Equity                        
Issuance of common stock under employee stock compensation plan (in shares)         105              
Issuance of common stock under employee stock compensation plans 179             179        
Share-based compensation 2,324             2,324        
Net loss (15,076)                   (15,076)  
Balance at end of period (in shares) at Mar. 31, 2020       0 49,732              
Balance at end of period at Mar. 31, 2020 104,630     $ 0 $ 50     600,182     (495,602) $ 0
Balance at beginning of period (in shares) at Dec. 31, 2019       0 49,627              
Balance at beginning of period at Dec. 31, 2019 117,203     $ 0 $ 50     597,679     (480,526)  
Increase (Decrease) in Stockholders' Equity                        
Net loss (33,665)                      
Balance at end of period (in shares) at Jun. 30, 2020       0 89,489              
Balance at end of period at Jun. 30, 2020 238,041     $ 0 $ 89     752,143     (514,191) 0
Balance at beginning of period (in shares) at Mar. 31, 2020       0 49,732              
Balance at beginning of period at Mar. 31, 2020 104,630     $ 0 $ 50     600,182     (495,602) 0
Increase (Decrease) in Stockholders' Equity                        
Issuance of common stock, net of issuance costs (in shares)           28,503 8,649          
Issuance of common stock, net of issuance costs   $ 116,883 $ 33,237     $ 28 $ 9   $ 116,855 $ 33,228    
Issuance of common stock under the exercise of pre-funded warrants (in shares)         2,500              
Issuance of common stock under the exercise of pre-funded warrants 0       $ 2     (2)        
Issuance of common stock under employee stock compensation plan (in shares)         105              
Issuance of common stock under employee stock compensation plans 7             7        
Share-based compensation 1,873             1,873        
Net loss (18,589)                   (18,589)  
Balance at end of period (in shares) at Jun. 30, 2020       0 89,489              
Balance at end of period at Jun. 30, 2020 238,041     $ 0 $ 89     752,143     (514,191) 0
Balance at beginning of period (in shares) at Dec. 31, 2020       0 90,121              
Balance at beginning of period at Dec. 31, 2020 191,563     $ 0 $ 90     756,543     (565,073) 3
Increase (Decrease) in Stockholders' Equity                        
Issuance of common stock under employee stock compensation plan (in shares)         49              
Issuance of common stock under employee stock compensation plans 129             129        
Share-based compensation 2,292             2,292        
Net loss (26,795)                   (26,795)  
Unrealized loss on available for sale securities, net of tax (1)                     (1)
Balance at end of period (in shares) at Mar. 31, 2021       0 90,170              
Balance at end of period at Mar. 31, 2021 167,188     $ 0 $ 90     758,964     (591,868) 2
Balance at beginning of period (in shares) at Dec. 31, 2020       0 90,121              
Balance at beginning of period at Dec. 31, 2020 191,563     $ 0 $ 90     756,543     (565,073) 3
Increase (Decrease) in Stockholders' Equity                        
Net loss (56,938)                      
Balance at end of period (in shares) at Jun. 30, 2021       0 90,387              
Balance at end of period at Jun. 30, 2021 139,573     $ 0 $ 90     761,491     (622,011) 3
Balance at beginning of period (in shares) at Mar. 31, 2021       0 90,170              
Balance at beginning of period at Mar. 31, 2021 167,188     $ 0 $ 90     758,964     (591,868) 2
Increase (Decrease) in Stockholders' Equity                        
Issuance of common stock under employee stock compensation plan (in shares)         217              
Issuance of common stock under employee stock compensation plans 448             448        
Share-based compensation 2,079             2,079        
Net loss (30,143)                   (30,143)  
Unrealized loss on available for sale securities, net of tax 1                     1
Balance at end of period (in shares) at Jun. 30, 2021       0 90,387              
Balance at end of period at Jun. 30, 2021 $ 139,573     $ 0 $ 90     $ 761,491     $ (622,011) $ 3